Psychotropic Medication Use Up in Children, Teens With Type 1 Diabetes
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, Oct. 5, 2023 -- Dispensing of psychotropic medication increased among children and adolescents with type 1 diabetes (T1D) from 2006 to 2019, according to a study published online Oct. 3 in JAMA Network Open.
Shengxin Liu, from the Karolinska Institutet in Solna, Sweden, and colleagues examined trends and patterns of psychotropic medication dispensing among 13,200 children and adolescents with T1D in Sweden between 2006 and 2019. Trends were compared to those among more than 3.7 million children in the general population without T1D.
The researchers found that psychotropic medication dispensing increased from 0.85 to 3.84 percent among children and from 2.72 to 13.54 percent among adolescents with T1D, consistently higher than their peers without T1D. Hypnotics, attention-deficit/hyperactivity disorder medications, anxiolytics, and selective serotonin reuptake inhibitors were the most commonly dispensed medications, and all exhibited increasing trends. Psychiatric care was the primary prescription source among those with T1D, and up to 50.1 percent of treatments lasted more than 12 months.
"These findings call for further in-depth investigations into the benefits and risks of psychotropic medications within this population and highlight the importance of integrating pediatric diabetes care and mental health care for early detection of psychological needs and careful monitoring of medication use," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
American Diabetes Association, June 21-24
The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world...
ADA: Inhaled Insulin Shows Promise for Adults With Type 1 Diabetes
THURSDAY, June 27, 2024 -- Inhaled insulin is associated with improved hemoglobin A1c (HbA1c) levels over 16 weeks among adults with type 1 diabetes when compared to usual care...
ADHD Meds May Help Control Opioid Use Disorder in Pregnancy
TUESDAY, June 25, 2024 -- Psychostimulants may help opioid use disorder (OUD) outcomes in pregnant women, according to a study published online June 11 in Nature Mental...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.